(Q34443235)

2 August 2017

1 reference

title

Novel approaches to the treatment of progressive renal disease (English)

1 reference

2 August 2017

Gilbert RE

1

1 reference

2 August 2017

Kelly DJ

series ordinal

2

1 reference

2 August 2017

Atkins RC

series ordinal

3

1 reference

2 August 2017

publication date

1 April 2001

1 reference

Current Opinion in Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

183-189

1 reference

Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Antihypertensive effects of fasidotril, a dual inhibitor of neprilysin and angiotensin-converting enzyme, in rats and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

New classes of antihypertensive drugs: therapeutic potentials

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Advanced glycation end products: a Nephrologist's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Protein kinase C: structure, function, and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Protein kinases C: potential targets for intervention in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

TGF-beta- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

PDGF and IL-1 induce and activate specific protein kinase C isoforms in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Visualization of dynamic trafficking of a protein kinase C betaII/green fluorescent protein conjugate reveals differences in G protein-coupled receptor activation and desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Thromboxane stimulation of mesangial cell fibronectin synthesis is signalled by protein kinase C and modulated by cGMP

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Expression of protein kinase C isoforms in renal tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4892%2801%2900023-6

7 January 2021

10.1016/S1471-4892(01)00023-6

Identifiers

DOI

1 reference

2 August 2017

1 reference